EXHIBIT 31.1

                           Omnimed International, Inc.

CERTIFICATION PURSUANT TO SARBANES-OXLEY SECTION 302

I, Milton Hauser, certify that:

1.  I  have   reviewed  this   quarterly   report  on  Form  10-QSB  of  Omnimed
International, Inc.;

2. Based on my  knowledge,  this  quarterly  report  does not contain any untrue
statement of a material fact or omit to state a material fact  necessary to make
the statements made, in light of the  circumstances  under which such statements
were made, not  misleading  with respect to the period covered by this quarterly
report;

3.  Based  on my  knowledge,  the  financial  statements,  and  other  financial
information  included in this quarterly  report,  fairly present in all material
respects the financial  condition,  results of operations  and cash flows of the
issuer as of, and for, the periods presented in this quarterly report;

4. The issuer's other certifying  officer and I are responsible for establishing
and maintaining  disclosure  controls and procedures (as defined in Exchange Act
Rules 13a-15(e) and 15d-15(e)) for the issuer and have:

     (a)  Designed  such  disclosure  controls  and  procedures  or caused  such
          disclosure   controls  and   procedures  to  be  designed   under  our
          supervision,  to ensure  that  material  information  relating  to the
          issuer including its consolidated  subsidiary,  is made known to us by
          others within those entities,  particularly during the period in which
          this report is being prepared; and

     (b)  Evaluated the  effectiveness of the issuer's  disclosure  controls and
          procedures  and  presented  in this report our  conclusions  about the
          effectiveness of the disclosure controls and procedures, as of the end
          of the period covered by this report based on such evaluation; and

     (c)  Disclosed in this report any change in the issuer's  internal  control
          over financial reporting that occurred during the issuer's most recent
          fiscal  quarter (the issuer's  fourth fiscal quarter in the case of an
          annual report) that has materially  affected,  or is reasonably likely
          to materially  affect,  the issuer's  internal  control over financial
          reporting;

5. The issuer's other certifying officer and I have disclosed, based on our most
recent evaluation of internal control over financial reporting,  to the issuer's
auditors and the audit  committee of the issuer's board of directors (or persons
performing the equivalent functions);

     (a)  All significant  deficiencies and material weaknesses in the design or
          operation  of internal  control  over  financial  reporting  which are
          reasonably  likely to adversely affect the issuer's ability to record,
          process, summarize and report financial information; and

     (b)  Any fraud, whether or not material,  that involves management or other
          employees  who  have  a  significant  role  in the  issuer's  internal
          controls over financial reporting.



                               OMNIMED INTERNATIONAL, INC.
Date: November 21, 2005        By: /s/ Milton Hauser
                                  -----------------
                                  Milton Hauser
                                  President, Chief
                                  Executive Officer,
                                  Acting Chief Financial Officer